Auxilium Pharmaceuticals Shares Down 20.1% Since SmarTrend's Sell Call (AUXL)
SmarTrend identified a Downtrend for Auxilium Pharmaceuticals (NASDAQ:AUXL) on August 21st, 2012 at $23.16. In approximately 5 months, Auxilium Pharmaceuticals has returned 20.06% as of today's recent price of $18.51.
In the past 52 weeks, shares of Auxilium Pharmaceuticals have traded between a low of $16.98 and a high of $29.37 and are now at $18.51, which is 9% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.4% while the 200-day MA has remained constant.
Auxilium Pharmaceuticals Inc. develops and commercializes pharmaceutical products that target urologic and sexual health disorders. The company's marketed product ,TESTIM, is a proprietary, topical 1% testosterone gel indicated for the treatment of hypogonadism.
SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Auxilium Pharmaceuticals.
Log in and add Auxilium Pharmaceuticals (AUXL) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.
Keywords: spotlights Auxilium Pharmaceuticals